Two genes, <i>ADAMTS7</i> and <i>THRAP3</i>, warrant further investigation as potential targets for therapeutic interventions to manage MASLD and depression among Mexican Americans. The gene discussed is ADAMTS7; the disease is depressive symptom measurement.